Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine GITS and Valsartan in Essential Hypertension
NCT01071122Phase 4Completed
- Sponsor
- Bayer
- Start
- Jan 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nifedipine and valsartan in essential hypertension (3 arms), sponsored by Bayer. Primary endpoint: Central systolic blood pressure at 8 weeks. Started Jan 2010; status: completed.
02
Drugs
nifedipinevalsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01071122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071122.